PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Blood, Stem Cell and Cancer Research Program, St Vincent\'s Applied Medical Research Centre, and Department of Haematology and BM Transplant, St Vincent\'s Hospital Sydney, NSW, Australia.\', \'Statewide BMT Program and Pathology Services, Royal Hobart Hospital, Hobart, TAS, Australia.\', \'Blood, Stem Cell and Cancer Research Program, St Vincent\'s Applied Medical Research Centre, and Department of Haematology and BM Transplant, St Vincent\'s Hospital Sydney, NSW, Australia; St Vincent\'s Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia. Electronic address: d.ma@amr.org.au.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1465-3249(21)00883-510.1016/j.jcyt.2021.10.009
?:hasPublicationType
?:journal
  • Cytotherapy
is ?:pmid of
?:pmid
?:pmid
  • 35086777
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.144
?:rankingScore_hIndex
  • 72
?:title
  • Meeting the COVID challenge: Optimizing vCD34+ in cryopreserved HPC samples for implementation of an external QA Program.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35086777>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35086777>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all